| Auxilium Pharmaceuticals, Inc. | (NQ: AUXL) |
|
USD
|
|
Official Closing Price
/ Updated: /
|
| View: | Quote | News | Research |
May 25, 2013
Auxilium Pharmaceuticals was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual health. The company's focus is on treating diseases and conditions that accompany aging. The premise is simple: "Many of the serious health problems that affect men and women as they age can be treated successfully. In areas such as urologic and sexual health, energy, mood, muscle mass and bone density, Auxilium is working to develop therapies designed to restore lost function and help people live healthier lives." The company has one Food and Drug Administration (FDA) approved product currently on the market for hypogonadism, called Testim (1% testosterone). Auxilium is also working on clinical and pre-clinical programs for Dupuytren's Contracture, Peyronie's disease, frozen shoulder syndrome, overactive bladder, and androgen replacement. Auxilium Pharmaceuticals is located in Malvern, PA, and employs about 269 professionals.
)